Agrenvec receives from the Madrid Community Government the concession of the project called "Use of Plants as Biofactory to Produce New Protease Inhibitors From Human TFPI and TFPI-2 With Antimetastatic and Antiangiogenic Potential in Cancer Therapy" for the development of new molecules of cancer development. The project receives the highest evaluation from de Madrid Community Government and its granted with 310.000 euros.